Klotho Neurosciences, Inc.

OTCPK:LEAS Rapport sur les actions

Capitalisation boursière : US$313.5k

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Anew Medical Bilan de santé

Santé financière contrôle des critères 1/6

Anew Medical has a total shareholder equity of $698.2K and total debt of $1.3M, which brings its debt-to-equity ratio to 193%. Its total assets and total liabilities are $2.3M and $1.6M respectively.

Informations clés

193.0%

Ratio d'endettement

US$1.35m

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$2.14k
Fonds propresUS$698.19k
Total du passifUS$1.60m
Total des actifsUS$2.29m

Mises à jour récentes de la santé financière

Pas de mise à jour

Recent updates

Analyse de la situation financière

Passif à court terme: LEAS's short term assets ($7.4K) do not cover its short term liabilities ($1.6M).

Passif à long terme: LEAS has no long term liabilities.


Historique et analyse du ratio d'endettement

Niveau d'endettement: LEAS's net debt to equity ratio (192.7%) is considered high.

Réduire la dette: Insufficient data to determine if LEAS's debt to equity ratio has reduced over the past 5 years.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: LEAS has less than a year of cash runway based on its current free cash flow.

Prévisions de trésorerie: LEAS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 41.8% each year


Découvrir des entreprises saines